Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4635572)

Published in Arthritis Res Ther on November 06, 2015

Authors

Cedo M Bagi1, Edwin Berryman2, David E Zakur3, Dean Wilkie4, Catharine J Andresen5

Author Affiliations

1: Global Science and Technology, Pfizer Global Research and Development, Pfizer Inc., 100 Eastern Point Road, Groton, CT, 06340, USA. cedo.bagi@pfizer.com.
2: Comparative Medicine, Global Science and Technology, Pfizer Global Research and Development, Pfizer Inc., 100 Eastern Point Road, Groton, CT, 06340, USA. edwin.r.berryman@pfizer.com.
3: Comparative Medicine, Global Science and Technology, Pfizer Global Research and Development, Pfizer Inc., 100 Eastern Point Road, Groton, CT, 06340, USA. david.zakur.@pfizer.com.
4: Investigative Pathology, Drug Safety Research and Development, Pfizer Inc., 100 Eastern Point Road, Groton, CT, 06340, USA. Dean.Wilkie@pfizer.com.
5: Comparative Medicine, Global Science and Technology, Pfizer Global Research and Development, Pfizer Inc., 100 Eastern Point Road, Groton, CT, 06340, USA. catharine.j.andresen@pfizer.com.

Associated clinical trials:

The Effect of Zoledronic Acid on Patients With Osteoarthritis of the Hip | NCT04303026

Articles cited by this

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med (2001) 16.81

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum (2000) 11.84

Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med (2000) 11.12

Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum (2006) 4.75

Osteoarthritis: an update with relevance for clinical practice. Lancet (2011) 4.18

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum (2006) 3.60

Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis (1993) 2.78

Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum (1995) 2.51

Analysis of cartilage matrix fixed charge density and three-dimensional morphology via contrast-enhanced microcomputed tomography. Proc Natl Acad Sci U S A (2006) 2.27

The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum (2004) 2.22

Animal models of osteoarthritis. J Musculoskelet Neuronal Interact (2001) 1.99

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89

The relationship between osteoarthritis and osteoporosis in the general population: the Chingford Study. Ann Rheum Dis (1994) 1.82

Biomechanics of mammalian terrestrial locomotion. Science (1990) 1.81

The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat. Osteoarthritis Cartilage (2010) 1.77

Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum (2004) 1.74

PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling. J Bone Miner Res (2011) 1.72

Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact (2001) 1.70

Induction of osteoarthritis in the rat by surgical tear of the meniscus: Inhibition of joint damage by a matrix metalloproteinase inhibitor. Osteoarthritis Cartilage (2002) 1.67

The effect of alendronate on progression of spinal osteophytes and disc-space narrowing. Ann Rheum Dis (2008) 1.61

Thickness of human articular cartilage in joints of the lower limb. Ann Rheum Dis (1999) 1.60

Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's law: the bone modeling problem. Anat Rec (1990) 1.60

Animal models of arthritis: relevance to human disease. Toxicol Pathol (1999) 1.53

Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum (2010) 1.51

Should subchondral bone turnover be targeted when treating osteoarthritis? Osteoarthritis Cartilage (2008) 1.50

Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression. Bone (2014) 1.47

Articular cartilage: structure, injuries and review of management. Br Med Bull (2008) 1.46

Quantitative assessment of articular cartilage morphology via EPIC-microCT. Osteoarthritis Cartilage (2008) 1.44

A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) (2006) 1.40

3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med Biol Eng Comput (2000) 1.26

Examination of subchondral bone architecture in experimental osteoarthritis by microscopic computed axial tomography. Arthritis Rheum (1988) 1.24

The role of biomechanics in the initiation and progression of OA of the knee. Best Pract Res Clin Rheumatol (2010) 1.23

The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord (2006) 1.21

The clinical utility of bone marker measurements in osteoporosis. J Transl Med (2013) 1.21

Nondestructive assessment of sGAG content and distribution in normal and degraded rat articular cartilage via EPIC-microCT. Osteoarthritis Cartilage (2009) 1.20

Solute transport in the deep and calcified zones of articular cartilage. Osteoarthritis Cartilage (2007) 1.14

Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol (2011) 1.14

Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med (2011) 1.12

A review of translational animal models for knee osteoarthritis. Arthritis (2012) 1.12

Biochemical and mechanical properties of subchondral bone in osteoarthritis. Biorheology (2004) 1.11

The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis (2013) 1.10

Musculoskeletal ontogeny, phylogeny, and functional adaptation. J Biomech (1991) 1.10

Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum (2009) 1.07

The normal human chondro-osseous junctional region: evidence for contact of uncalcified cartilage with subchondral bone and marrow spaces. BMC Musculoskelet Disord (2006) 1.07

Computed tomography-osteoabsorptiometry for assessing the density distribution of subchondral bone as a measure of long-term mechanical adaptation in individual joints. Skeletal Radiol (1989) 1.06

Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthritis Cartilage (2010) 1.05

Importance of subchondral bone to articular cartilage in health and disease. Top Magn Reson Imaging (1999) 1.04

Detection of mechanical injury of articular cartilage using contrast enhanced computed tomography. Osteoarthritis Cartilage (2011) 1.01

Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis. J Rheumatol (1999) 1.01

The tidemark of the chondro-osseous junction of the normal human knee joint. J Mol Histol (2005) 1.00

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. Osteoarthritis Cartilage (2007) 1.00

Four distinct chondrocyte populations in the fetal bovine growth plate: highest expression levels of PTH/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1-34) and PTHrP (1-40). Exp Cell Res (2002) 0.96

Chondroprotective effect of alendronate in a rabbit model of osteoarthritis. J Orthop Res (2011) 0.96

Human bipeds use quadrupedal coordination during locomotion. Ann N Y Acad Sci (2009) 0.95

Cartilaginous repair of full-thickness articular cartilage defects is induced by the intermittent activation of PTH/PTHrP signaling. Osteoarthritis Cartilage (2011) 0.93

Cartilage, bone and synovial histomorphometry in animal models of osteoarthritis. Osteoarthritis Cartilage (2010) 0.93

Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis (2012) 0.91

Comparative bone anatomy of commonly used laboratory animals: implications for drug discovery. Comp Med (2011) 0.91

Biomarkers: in combination they may do better. Arthritis Res Ther (2009) 0.89

Effect of parathyroid hormone on type X and type II collagen expression in mesenchymal stem cells from osteoarthritic patients. Tissue Eng Part A (2010) 0.89

Enhancement of subchondral bone quality by alendronate administration for the reduction of cartilage degeneration in the early phase of experimental osteoarthritis. Clin Exp Med (2011) 0.88

Studies of tibial subchondral bone density and its significance. J Bone Joint Surg Am (1985) 0.88

Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation. Osteoarthritis Cartilage (2012) 0.87

The effect of bone remodeling inhibition by zoledronic acid in an animal model of cartilage matrix damage. Osteoarthritis Cartilage (2002) 0.86

Comparison of osteopenic changes in cancellous bone induced by ovariectomy and/or immobilization in adult rats. Anat Rec (1994) 0.86

Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model. Acta Pharmacol Sin (2012) 0.86

Terminology of osteoarthritis cartilage and bone histopathology - a proposal for a consensus. Osteoarthritis Cartilage (2010) 0.86

The area of the tidemark in osteoarthritis--a three-dimensional stereological study in 21 patients. APMIS (2005) 0.85

Obesity, knee osteoarthritis and knee arthroplasty: a review. BMC Sports Sci Med Rehabil (2013) 0.84

Alternative approach to assessment of bone quality using micro-computed tomography. Bone (2004) 0.82

Diagnostic and prognostic value of bone biomarkers in progressive knee osteoarthritis: a 6-year follow-up study in middle-aged subjects. Osteoarthritis Cartilage (2013) 0.82

Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort. Osteoarthritis Cartilage (2013) 0.82

Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice. Arthritis Res Ther (2015) 0.82

Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J Proteome Res (2007) 0.80

Does osteoarthrosis depend on growth of the mineralized layer of cartilage? Clin Orthop Relat Res (1993) 0.80

The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. J Endocrinol Invest (2011) 0.80

Intra-articular zoledronic acid in a rat osteoarthritis model: significant reduced synovitis may indicate chondroprotective effect. Knee Surg Sports Traumatol Arthrosc (2014) 0.78

Targeting subchondral bone in osteoporotic osteoarthritis. Arthritis Res Ther (2014) 0.77